Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells

被引:5
|
作者
Zhu, Leqing [1 ,2 ]
Tang, Fen [1 ,2 ]
Lei, Zhiwei [1 ,2 ,3 ]
Guo, Chengbin [1 ,2 ]
Song, Yueqi [1 ,2 ]
Huang, Junqing [4 ]
Xia, Xichun [1 ,2 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, 601 West Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
[2] Jinan Univ, Sch Pharm, 601 West Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Dept Basic Med Res, Affiliated Hosp 6, Qingyuan Peoples Hosp, Qingyuan, Guangdong, Peoples R China
[4] Jinan Univ, Sch Tradit Chinese Med, Formula Pattern Res Ctr, 601 West Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
ABC-DLBCL; apoptosis; GLS1; MALT1; protease; ROS; KAPPA-B ACTIVATION; GLUTAMINASE EXPRESSION; LYMPHOMA; CLEAVAGE; SURVIVAL; CARMA1; PHOSPHORYLATION; MITOCHONDRIA; DOXORUBICIN; STRATEGIES;
D O I
10.1002/mc.23122
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucosa-associated lymphoid tissue lymphoma translocation protein-1 (MALT1) protease presents crucial antiapoptotic properties in activated B cell-like diffuse large B-cell lymphoma (ABC-DLBCL); however, the mechanism is unclear. Here, we reported that inhibition of MALT1 protease in ABC-DLBCL cells led to cell apoptosis, along with elevated mitochondrial reactive oxygen species production and a reduced oxygen consumption rate. These alterations induced by MALT1 protease inhibition were associated with reduced expression of glutaminase (GLS1) and glutathione levels. We further show that MALT1 protease was required for the activation and nuclear translocation of c-Jun, which functions as a transcription factor of the GLS1 gene by binding directly to its promoter region. Taken together, MALT1 protease maintained mitochondrial redox homeostasis and mitochondrial bioenergetics through the MALT1-c-Jun-GLS1-coupled metabolic pathway to defend against apoptosis in ABC-DLBCL cells, which raises exciting possibilities regarding targeting of the MALT1-c-Jun-GLS1 axis as a potential therapeutic strategy against ABC-DLBCL.
引用
收藏
页码:2340 / 2352
页数:13
相关论文
共 38 条
  • [31] Detection of MALT1 Gene Rearrangements in BAL Fluid Cells for the Diagnosis of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma
    Kido, Takashi
    Yatera, Kazuhiro
    Noguchi, Shingo
    Sakurai, Yasumasa
    Nagata, Shuya
    Kozaki, Minako
    Tokuyama, Susumu
    Ogoshi, Takaaki
    Kawanami, Toshinori
    Yoshii, Chiharu
    Mukae, Hiroshi
    CHEST, 2012, 141 (01) : 176 - 182
  • [32] HCK Transcription Is Regulated By AP1, NF-Kb and STAT3 Transcription Factors in MYD88 Mutated WM and ABC-DLBCL Cells
    Liu, Xia
    Chen, Jiaji G.
    Chen, Jie
    Xu, Lian
    Tsakmaklis, Nicholas
    Demos, Maria
    Patterson, Christopher J.
    Castillo, Jorge J.
    Hunter, Zachary
    Treon, Steven P.
    Yang, Guang
    BLOOD, 2016, 128 (22)
  • [33] Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells
    Yan, Binjie
    Belke, Darrell
    Gui, Yu
    Chen, Yong-Xiang
    Jiang, Zhi-Sheng
    Zheng, Xi-Long
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [34] Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells
    Binjie Yan
    Darrell Belke
    Yu Gui
    Yong-Xiang Chen
    Zhi-Sheng Jiang
    Xi-Long Zheng
    Cell Death Discovery, 9
  • [35] Suppression of regulatory T cells (Tregs) in vivo by small molecule targeting of the mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1)
    Finnberg, N.
    Oberg, F.
    Mangsbo, S.
    Kerzeli, I.
    Fletcher, E.
    Kallin, A.
    Christodoulidou, A.
    Sedig, S.
    Sternbeck, A. K.
    Bylund, J.
    Moses, S.
    Oden, L. Salvador
    Kullman-Magnusson, M.
    Henderson, I.
    Beisel, H. G.
    Ersmark, K.
    Karlstrom, S.
    Bethell, R.
    Albertella, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E74 - E74
  • [36] Preclinical evaluation of a novel interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor in combination with PI3K inhibitor copanlisib or BTK inhibitors in ABC-DLBCL
    Lange, Martin
    Wengner, Antje Margret
    Bothe, Ulrich
    Boemer, Ulf
    Nubbemeyer, Reinhard
    Siebeneicher, Holger
    Steuber, Holger
    Guenther, Judith
    Potze, Lisette
    Schmidt, Nicole
    Politz, Oliver
    Doecke, Wolf-Dietrich
    Lagkadinou, Eleni
    Zollner, Thomas M.
    von Nussbaum, Franz
    Mumberg, Dominik
    Steinmeyer, Andreas
    Brands, Michael
    Ziegelbauer, Karl
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells (vol 206, pg 2313, 2009)
    Ferch, Uta
    Kloo, Bernhard
    Gewies, Andreas
    Pfander, Vera
    Duewel, Michael
    Peschel, Christian
    Krappmann, Daniel
    Ruland, Juergen
    JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (12): : 2851 - 2851
  • [38] Inhibition of MALT1 Protease Activity Is Selectively Toxic for Activated B Cell(A)over-tilde,(A)over-cap-Like Diffuse Large B Cell Lymphoma Cells
    Ferch, Uta
    Kloo, Bernhard
    Gewies, Andreas
    Pfaender, Vera
    Duewel, Michael
    Peschel, Christian
    Krappmann, Daniel
    Ruland, Juergen
    BLOOD, 2009, 114 (22) : 522 - 523